YES PHARMACEUTICAL DEVELOPMENT SERVICES GMBH
ItalyAll drugs from this manufacturer
-
It is an anticancer drug used in adults for the treatment of metastatic or locally advanced breast cancer (when other therapies have not been effective) and for advanced or metastatic liposarcoma (a tumor of the fatty tissue) after the failure of a previous therapy.
Dosage form: solution for injection
Active substance Dosage eribulin - ATC: L01XX41